Head-to-head · Cost-Efficiency Index
GOAL.MD vs NuuVim
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
GOAL.MD
Shoppers comparing a named physician-led practice, who won't mistake the $149 ad price for the ongoing rate.
Visit GOAL.MDNuuVim
Cost-first shoppers who want low-cost compounded GLP-1s (injection or oral), flat all-dose pricing.
Visit NuuVimThe verdict
GOAL.MD takes it, leading the Cost-Efficiency Index 71 to 70. GOAL.MD (goal.md) is a physician-run telehealth weight-loss practice, led by Chief Physician Dr. Michael Mimlitz, MD. NuuVim still earns a C — Cost-first shoppers who want low-cost compounded GLP-1s (injection or oral), flat all-dose pricing.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs GOAL.MD.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | GOAL.MD | NuuVim |
|---|---|---|
| Cost-Efficiency Index | 71/100 | 70/100 |
| Semaglutide / mo | $199/mo (promotional rate, compounded) | $79/mo (all doses, 3-mo plan, new patients only, compounded) |
| Tirzepatide / mo | $299/mo (compounded) | $133/mo (all doses, 3-mo plan, new patients only, compounded) |
| Semaglutide / yr (modeled) | $2,388 | $948 |
| Tirzepatide / yr (modeled) | $3,588 | $1,596 |
| Coverage | All 50 states | Coverage not published |
| Oral / sublingual | No | Yes |
| Brand-name access | Yes | Yes |
| Rank here | #81 | #88 |
GOAL.MD
71/100Where the value is
- Named Chief Physician (Dr. Michael Mimlitz, MD) rather than an anonymous provider network
- Multiple product tiers (standard, micro-dose, combination 'Synergy') for different budgets and needs
- 3-month bundle discount available on the combination product ($547/mo vs. $597/mo single-month)
The tradeoffs
- The widely advertised '$149' price is a first-month-only discount; the standing rate is $199/mo semaglutide and $299/mo tirzepatide — more than double the headline for tirzepatide
- No named compounding pharmacy — only generic '503A & 503B licensed U.S. pharmacies' language
NuuVim
70/100Where the value is
- Low compounded entry pricing — semaglutide from $79/mo, tirzepatide from $133/mo, flat all-dose pricing
- Both injectable and oral compounded options for semaglutide and tirzepatide (oral access is uncommon)
- LegitScript Certified and HIPAA-compliant
The tradeoffs
- There is no month-to-month plan: every rate is billed as one three-month payment
- The advertised $79 and $133 are introductory rates for customers new to GLP-1s; on renewal they become $133 and $199.67
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.